Human medicines European public assessment report (EPAR): Ranibizumab Midas, ranibizumab, Date of authorisation: 19/09/2024, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 29 October 2024 - 14:34

Human medicines European public assessment report (EPAR): Ranibizumab Midas, ranibizumab, Date of authorisation: 19/09/2024, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/ranibizumab-midas

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters